Differential Effects of Cyproterone Acetate vs Spironolactone on Serum High-Density Lipoprotein and Prolactin Concentrations in the Hormonal Treatment of Transgender Women.


INTRODUCTION Spironolactone and cyproterone acetate (CPA) are the two main antiandrogen medications used in feminizing hormone therapy in transgender women. Previous studies have suggested that these two agents might have opposite effects on high-density lipoprotein (HDL) level when used in this context, and limited data have suggested CPA increases… (More)
DOI: 10.1016/j.jsxm.2016.09.012


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics